JPH09509138A - ターフェナジン及びイブプロフェンの安定な製剤組成物 - Google Patents
ターフェナジン及びイブプロフェンの安定な製剤組成物Info
- Publication number
- JPH09509138A JPH09509138A JP7512634A JP51263495A JPH09509138A JP H09509138 A JPH09509138 A JP H09509138A JP 7512634 A JP7512634 A JP 7512634A JP 51263495 A JP51263495 A JP 51263495A JP H09509138 A JPH09509138 A JP H09509138A
- Authority
- JP
- Japan
- Prior art keywords
- acid
- ibuprofen
- mixture
- taphenazine
- taphenadone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1. a)治療上鎮痛有効量のイブプロフェン、又は製薬上受入れられるその塩、 b)治療上抗ヒスタミン有効量のタ−フェナジン、又は製薬上受入れられるそ の塩、及び c)α-ヒドロキシカルボン酸 を含んでいる、化学的に安定な製剤組成物。 2.カルボン酸がジカルボン酸である、請求項1に記載の組成物。 3.カルボン酸が酒石酸である、請求項1に記載の組成物。 4.カルボン酸がタルトロン酸である、請求項1に記載の化合物。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US14252893A | 1993-10-25 | 1993-10-25 | |
US08/142,528 | 1993-10-25 | ||
PCT/US1994/010972 WO1995011677A1 (en) | 1993-10-25 | 1994-09-28 | A stable pharmaceutical composition of terfenadine and ibuprofen |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH09509138A true JPH09509138A (ja) | 1997-09-16 |
Family
ID=22500192
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP7512634A Ceased JPH09509138A (ja) | 1993-10-25 | 1994-09-28 | ターフェナジン及びイブプロフェンの安定な製剤組成物 |
Country Status (18)
Country | Link |
---|---|
US (1) | US5691352A (ja) |
EP (1) | EP0725639B1 (ja) |
JP (1) | JPH09509138A (ja) |
KR (1) | KR100338877B1 (ja) |
CN (1) | CN1060040C (ja) |
AT (1) | ATE197544T1 (ja) |
AU (1) | AU683093B2 (ja) |
CA (1) | CA2173467A1 (ja) |
DE (1) | DE69426306T2 (ja) |
DK (1) | DK0725639T3 (ja) |
ES (1) | ES2153863T3 (ja) |
FI (1) | FI117000B (ja) |
GR (1) | GR3035384T3 (ja) |
HU (1) | HU222887B1 (ja) |
NO (1) | NO308773B1 (ja) |
NZ (1) | NZ274423A (ja) |
PT (1) | PT725639E (ja) |
WO (1) | WO1995011677A1 (ja) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU763274B2 (en) * | 1998-02-06 | 2003-07-17 | Biocosmetics, S.L. | Composition for the treatment of halitosis |
JP2006515299A (ja) * | 2002-12-18 | 2006-05-25 | ワイス | 非ステロイド性抗炎症薬、充血除去薬および抗ヒスタミン薬の組成物 |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5962488A (en) | 1998-04-08 | 1999-10-05 | Roberts Laboratories, Inc. | Stable pharmaceutical formulations for treating internal bowel syndrome containing isoxazole derivatives |
CN101417131B (zh) * | 2007-10-22 | 2010-11-10 | 鲁南制药集团股份有限公司 | 一种用于治疗皮肤过敏性疾病的外用药物组合物 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4254129A (en) * | 1979-04-10 | 1981-03-03 | Richardson-Merrell Inc. | Piperidine derivatives |
US4285957A (en) * | 1979-04-10 | 1981-08-25 | Richardson-Merrell Inc. | 1-Piperidine-alkanol derivatives, pharmaceutical compositions thereof, and method of use thereof |
US4783465A (en) * | 1984-04-09 | 1988-11-08 | Analgesic Associates | Cough/cold mixtures comprising non-sedating antihistamine drugs |
US4999226A (en) * | 1988-06-01 | 1991-03-12 | Merrell Dow Pharmaceuticals Inc. | Pharmaceutical compositions for piperidinoalkanol-ibuprofen combination |
WO1992005783A1 (en) * | 1990-09-28 | 1992-04-16 | Merck & Co., Inc. | Ibuprofen-antihistamine combinations |
US5512300A (en) * | 1992-09-15 | 1996-04-30 | Warner-Lambert Company | Prevention of ibuprofen from forming low melting eutectics with other therapeutic agents in solid dosage forms |
-
1994
- 1994-09-28 KR KR1019960702078A patent/KR100338877B1/ko not_active IP Right Cessation
- 1994-09-28 EP EP94929374A patent/EP0725639B1/en not_active Expired - Lifetime
- 1994-09-28 DE DE69426306T patent/DE69426306T2/de not_active Expired - Lifetime
- 1994-09-28 CN CN94193911A patent/CN1060040C/zh not_active Expired - Lifetime
- 1994-09-28 ES ES94929374T patent/ES2153863T3/es not_active Expired - Lifetime
- 1994-09-28 CA CA002173467A patent/CA2173467A1/en not_active Withdrawn
- 1994-09-28 AT AT94929374T patent/ATE197544T1/de active
- 1994-09-28 US US08/624,362 patent/US5691352A/en not_active Expired - Lifetime
- 1994-09-28 NZ NZ274423A patent/NZ274423A/en not_active IP Right Cessation
- 1994-09-28 WO PCT/US1994/010972 patent/WO1995011677A1/en active IP Right Grant
- 1994-09-28 JP JP7512634A patent/JPH09509138A/ja not_active Ceased
- 1994-09-28 PT PT94929374T patent/PT725639E/pt unknown
- 1994-09-28 HU HU9601074A patent/HU222887B1/hu active IP Right Grant
- 1994-09-28 DK DK94929374T patent/DK0725639T3/da active
- 1994-09-28 AU AU78456/94A patent/AU683093B2/en not_active Expired
-
1996
- 1996-04-24 FI FI961756A patent/FI117000B/fi not_active IP Right Cessation
- 1996-04-24 NO NO961640A patent/NO308773B1/no not_active IP Right Cessation
-
2001
- 2001-02-07 GR GR20010400211T patent/GR3035384T3/el unknown
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU763274B2 (en) * | 1998-02-06 | 2003-07-17 | Biocosmetics, S.L. | Composition for the treatment of halitosis |
JP2006515299A (ja) * | 2002-12-18 | 2006-05-25 | ワイス | 非ステロイド性抗炎症薬、充血除去薬および抗ヒスタミン薬の組成物 |
Also Published As
Publication number | Publication date |
---|---|
DK0725639T3 (da) | 2000-12-11 |
CA2173467A1 (en) | 1995-05-04 |
FI117000B (fi) | 2006-05-15 |
AU683093B2 (en) | 1997-10-30 |
KR100338877B1 (ko) | 2002-12-05 |
NO961640D0 (no) | 1996-04-24 |
EP0725639B1 (en) | 2000-11-15 |
FI961756A (fi) | 1996-04-24 |
HU9601074D0 (en) | 1996-06-28 |
AU7845694A (en) | 1995-05-22 |
US5691352A (en) | 1997-11-25 |
KR960705565A (ko) | 1996-11-08 |
ES2153863T3 (es) | 2001-03-16 |
WO1995011677A1 (en) | 1995-05-04 |
CN1060040C (zh) | 2001-01-03 |
ATE197544T1 (de) | 2000-12-15 |
GR3035384T3 (en) | 2001-05-31 |
NO961640L (no) | 1996-04-24 |
CN1133560A (zh) | 1996-10-16 |
HU222887B1 (hu) | 2003-12-29 |
DE69426306T2 (de) | 2001-06-07 |
PT725639E (pt) | 2001-02-28 |
NO308773B1 (no) | 2000-10-30 |
FI961756A0 (fi) | 1996-04-24 |
HUT74577A (en) | 1997-01-28 |
EP0725639A1 (en) | 1996-08-14 |
NZ274423A (en) | 1997-10-24 |
DE69426306D1 (de) | 2000-12-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2291345B1 (en) | Co-crystals of duloxetine and naproxen | |
EP0707478B1 (en) | Improved nicotine lozenge | |
US20090117054A1 (en) | Sublingual spray for the treatment of pain | |
Lv et al. | Preparation, physicochemical characteristics and bioavailability studies of an atorvastatin hydroxypropyl-β-cyclodextrin complex | |
Meloun et al. | The thermodynamic dissociation constants of losartan, paracetamol, phenylephrine and quinine by the regression analysis of spectrophotometric data | |
Zhang et al. | Using dissolution and pharmacokinetics studies of crystal form to optimize the original iloperidone | |
JP2023113803A (ja) | シチシンのコハク酸塩およびその使用 | |
JP5101007B2 (ja) | 安定化された医薬製剤 | |
JPH09509138A (ja) | ターフェナジン及びイブプロフェンの安定な製剤組成物 | |
US20170354662A1 (en) | Methods and compositions for treating migraines using noribogaine | |
Takagi et al. | Effect of a new quinolone, sparfloxacin, on the pharmacokinetics of theophylline in asthmatic patients | |
Singla et al. | Zinc-aspirin complex: synthesis, physicochemical and biological evaluation | |
Takagi et al. | Comparative studies on interaction between theophylline and quinolones | |
US20040086559A1 (en) | Pharmaceutical tablet comprising paroextine mesylate | |
Wu et al. | Pharmacokinetic and pharmacodynamic evaluations of the zwitterionic metabolite of a new series of N-substituted soft anticholinergics | |
EA039058B1 (ru) | Фармацевтический состав, содержащий алимемазина тартрат | |
JP6862200B2 (ja) | ビルダグリプチン含有医薬組成物、医薬組成物におけるビルダグリプチンの臭い抑制方法、及び医薬組成物におけるビルダグリプチンの臭い抑制剤 | |
CN117500790A (zh) | 含有他喹莫德的药物产品和用于评估所述产品的纯度的方法 | |
EP1200088A2 (en) | Paracetamol and drotaverine containing composition | |
JP3062249B2 (ja) | ドーパミン再取込み阻害剤 | |
WO2022103620A1 (en) | Oral bilayer tablets comprising acetylsalicylic acid and pseudoephedrine, methods of preparing and using thereof | |
Rigby et al. | Propantheline bromide plasma level, urinary excretion and pharmacological data in a comparison of the bioavailability of three oral formulations of Pro-Banthine | |
JP2004123591A (ja) | 鼻炎治療用固形製剤 | |
Bharkad et al. | Journal of Pharmacreations | |
Saraganachari | Formulation and evaluation of sublingual tablets of an antiasthmatic drug |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20050208 |
|
RD12 | Notification of acceptance of power of sub attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7432 Effective date: 20050401 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20050509 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20050620 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20050805 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20051220 |
|
A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A712 Effective date: 20060502 |
|
A072 | Dismissal of procedure [no reply to invitation to correct request for examination] |
Free format text: JAPANESE INTERMEDIATE CODE: A073 Effective date: 20070605 |
|
A313 | Final decision of rejection without a dissenting response from the applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A313 Effective date: 20070718 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20071002 |